Literature DB >> 11896772

Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size.

Arlene S Rogachefsky1, Sirunya Silapunt, David J Goldberg.   

Abstract

BACKGROUND: Laser treatment of lower extremity telangiectases and small reticular veins has remained difficult because of vessel color, diameter, depth, and associated high-pressure flow. Traditionally, larger-caliber blue leg veins do not respond well to laser treatment. Nd:YAG laser (1064 nm) irradiation is absorbed by oxyhemoglobin and reduced hemoglobin and is associated with greater depth of penetration than other previously studied vascular lasers.
OBJECTIVE: To evaluate a millisecond contact-cooled 1064 nm Nd:YAG laser for the treatment of telangiectases and small reticular veins.
METHODS: Twenty-one lower extremity sites, with Fitzpatrick skin types I-IV, received two laser treatments separated by a 4 to 6-week period. Blue and red vessels, ranging in size from 0.25 to 4.0 mm were treated. Pulse durations of 10-50 msec were utilized at fluences of 90-187 J/cm2. Three months after the last treatment, patients were evaluated for vessel improvement and complications.
RESULTS: Seventy-one percent of lower extremity vessels had improvement graded as significant. All vessel colors and sizes were successfully treated. The only complication at 3 months was postinflammatory hyperpigmentation.
CONCLUSION: 1064 nm Nd:YAG laser irradiation with associated contact cooling is a safe and effective treatment for telangiectases and small reticular veins of the lower extremities.

Entities:  

Mesh:

Year:  2002        PMID: 11896772     DOI: 10.1046/j.1524-4725.2002.01141.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  7 in total

1.  Comparison of epidermal/dermal damage between the long-pulsed 1064 nm Nd:YAG and 755 nm alexandrite lasers under relatively high fluence conditions: quantitative and histological assessments.

Authors:  Ju Hwan Lee; So Ra Park; Jeong Ho Jo; Sung Yun Park; Young Kwon Seo; Sung Min Kim
Journal:  Photomed Laser Surg       Date:  2014-07       Impact factor: 2.796

2.  Long-pulsed 1064-nm and 755-nm lasers for C1 leg veins on skin type IV patients: a side-by-side comparison.

Authors:  Huyen Tran Ngoc Nguyen; Al-Niaimi Firas; Trung The Van
Journal:  Lasers Med Sci       Date:  2020-08-03       Impact factor: 3.161

3.  Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.

Authors:  Matheus Bertanha; Rodrigo Gibin Jaldin; Regina Moura; Rafael Elias Farres Pimenta; Jamil Victor de Oliveira Mariúba; Carlos Eduardo Pinheiro Lúcio Filho; Giovana Piteri Alcantara; Carlos Roberto Padovani; Winston Bonetti Yoshida; Marcone Lima Sobreira
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

Review 4.  Transcutaneous laser treatment of leg veins.

Authors:  Arne A Meesters; Luiza H U Pitassi; Valeria Campos; Albert Wolkerstorfer; Christine C Dierickx
Journal:  Lasers Med Sci       Date:  2013-11-13       Impact factor: 3.161

5.  Mathematical modeling of selective photothermolysis to aid the treatment of vascular malformations and hemangioma with pulsed dye laser.

Authors:  Gal Shafirstein; Lisa M Buckmiller; Milton Waner; Wolfgang Bäumler
Journal:  Lasers Med Sci       Date:  2007-02-01       Impact factor: 2.555

6.  Management of Facial Telangiectasias with Hand Cautery.

Authors:  Ioannis E Liapakis; Miriam Englander; Roven Sinani; Eleftherios I Paschalis
Journal:  World J Plast Surg       Date:  2015-07

7.  Use of high-power diode laser at 1060 nm for the treatment of vascular lesions.

Authors:  Gabriel Buendía Bordera; Jorge Gaviria Parada; Maribel Martí Giménez; María de Los Llanos Pérez; Júlia Oliva Morell; Gregorio Viera Mármol
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.